Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 50Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Celebrex

02 5Celecox

03 1celecox

PharmaCompass

01

Brand Name : Celebrex

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

02

Brand Name : Celecox

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Celecox

arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 249

2019 Revenue in Millions : 454

Growth (%) : -45

blank

03

Brand Name : Celecox

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Celecox

arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 17

2020 Revenue in Millions : 248

Growth (%) : -93

blank

04

Brand Name : Celebrex

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Celebrex

arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Musculoskeletal

Currency : USD

2022 Revenue in Millions : 338

2021 Revenue in Millions : 344

Growth (%) : -2

blank

05

Brand Name : Celebrex

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Celebrex

arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 331

2022 Revenue in Millions : 338

Growth (%) : -2

blank

06

Brand Name : Celecox

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Celecox

arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Anti-Inflammatory

Currency : USD

2018 Revenue in Millions : 443

2017 Revenue in Millions : 436

Growth (%) : 2%

blank

07

Brand Name : celecox

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : celecox

arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Anti-Inflammatory

Currency : USD

2016 Revenue in Millions : 428

2015 Revenue in Millions : 418

Growth (%) : 3

blank

08

Brand Name : Celecox

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Celecox

arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Anti-inflammatory

Currency : USD

2017 Revenue in Millions : 465

2016 Revenue in Millions : 457

Growth (%) : 2

blank

09

Brand Name : Celecox

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Celecox

arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 460

2018 Revenue in Millions : 458

Growth (%) : 1

blank

10

Brand Name : Celebrex

Celecoxib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Celebrex

Country
arrow
Fi Europe 2024
Not Confirmed

Celecoxib

Main Therapeutic Indication : Musculoskeletal

Currency : USD

2020 Revenue in Millions : 428

2019 Revenue in Millions : 526

Growth (%) : -19

blank